Ultrasonography surveillance improves prognosis of patients with hepatocellular carcinoma

  • Authors:
    • Hiroka Yamago
    • Atsushi Hiraoka
    • Taisei Murakami
    • Hirofumi Izumoto
    • Hidetaro Ueki
    • Marie Ochi
    • Toshihiko Aibiki
    • Tomonari Okudaira
    • Ryuichiro Iwasaki
    • Yoshifumi Suga
    • Kenichiro Mori
    • Hideki Miyata
    • Eiji Tsubouchi
    • Masato Kishida
    • Masashi Hirooka
    • Masanori Abe
    • Bunzo Matsuura
    • Tomoyuki Ninomiya
    • Yoichi Hiasa
    • Kojiro Michitaka
  • View Affiliations

  • Published online on: June 25, 2019     https://doi.org/10.3892/mco.2019.1888
  • Pages: 325-330
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

To examine the effectiveness of ultrasonography (US) for hepatocellular carcinoma (HCC) surveillance, the prognosis of HCC patients who underwent such screening at an expert medical institution or at general clinics were analyzed, as well as those without US surveillance. From October 2006 to December 2014, 872 patients with naïve HCC were enrolled and divided into the surveillance (S)‑group (n=398), who underwent follow‑up examinations with US, and the non‑S group (n=474). The S‑group was further subdivided into patients who underwent follow‑up surveillance at Ehime Prefectural Central Hospital, an expert medical institution (SE‑group, n=189), and those who received surveillance at general clinics (SG‑group, n=209). Prognosis and clinical characteristics were analyzed. In the non‑S group, the frequency of patients without viral hepatitis (NBNC‑HCC) and Tumor, Node, Metastasis stage was greater. As a result, the median survival time (MST) of the non‑S group was reduced, compared with the S group (non‑S group, 34.1 vs. S group, 68.2 months; P<0.001). Tumor size was significantly different between the SE‑ and SG‑groups (SE‑group, 2.0±1.0 vs. SG‑group, 2.5±1.3 cm; P<0.001), whereas tumor number (SE‑group: 1.5±1.1 vs. SG‑group, 1.7±1.2; P=0.164) and MST (SE‑group, 72.1 vs. SG‑group, 67.1 months; P=0.931) were not significantly different. Surveillance performed at either an expert medical institution or general clinic improved the prognosis of HCC patients. Dissemination of findings demonstrating the importance of surveillance for HCC to all clinicians as well as patients with chronic liver disease is important, and establishment of an effective surveillance strategy for NBNC‑HCC is required.
View Figures
View References

Related Articles

Journal Cover

September 2019
Volume 11 Issue 3

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Yamago, H., Hiraoka, A., Murakami, T., Izumoto, H., Ueki, H., Ochi, M. ... Michitaka, K. (2019). Ultrasonography surveillance improves prognosis of patients with hepatocellular carcinoma. Molecular and Clinical Oncology, 11, 325-330. https://doi.org/10.3892/mco.2019.1888
MLA
Yamago, H., Hiraoka, A., Murakami, T., Izumoto, H., Ueki, H., Ochi, M., Aibiki, T., Okudaira, T., Iwasaki, R., Suga, Y., Mori, K., Miyata, H., Tsubouchi, E., Kishida, M., Hirooka, M., Abe, M., Matsuura, B., Ninomiya, T., Hiasa, Y., Michitaka, K."Ultrasonography surveillance improves prognosis of patients with hepatocellular carcinoma". Molecular and Clinical Oncology 11.3 (2019): 325-330.
Chicago
Yamago, H., Hiraoka, A., Murakami, T., Izumoto, H., Ueki, H., Ochi, M., Aibiki, T., Okudaira, T., Iwasaki, R., Suga, Y., Mori, K., Miyata, H., Tsubouchi, E., Kishida, M., Hirooka, M., Abe, M., Matsuura, B., Ninomiya, T., Hiasa, Y., Michitaka, K."Ultrasonography surveillance improves prognosis of patients with hepatocellular carcinoma". Molecular and Clinical Oncology 11, no. 3 (2019): 325-330. https://doi.org/10.3892/mco.2019.1888